Pulmonary Embolism News and Research

RSS

A pulmonary embolism is a sudden blockage in a lung artery. The cause is usually a blood clot in the leg called a deep vein thrombosis that breaks loose and travels through the bloodstream to the lung.

What is the association between COVID-19 and thrombotic events?

In a new study, researchers assessed the association of COVID-19 and influenza with thrombotic events among patients.

18 Aug 2022

Study details post-COVID-19 symptoms and conditions among children and adolescents in the US

In a new study, researchers assessed the incidence of post-COVID-19 symptoms and conditions among children and adolescents.

9 Aug 2022

French study on cardiovascular disease incidence during COVID pandemic and vaccination campaign

Researchers describe failures of the French healthcare system as reflected by increased hospitalizations due to certain acute cardiovascular diseases in 2021.

7 Aug 2022

Researchers delve deeper into the structure of protein receptor crucial for cardiovascular health

5 Aug 2022

Higher suPAR levels linked with increased risk of blood clot formation

Blood clots are thought to occur in as many as a third of patients hospitalized with COVID-19. In many cases these clots can be deadly, such as pulmonary embolisms-;blood clots that travel to the lungs. In fact, in nearly one third of patients with COVID-19, these clots led to death.

4 Aug 2022

RINVOQ® (upadacitinib) Approved by European Commission as an Oral Treatment for Adults with Active Non-Radiographic Axial Spondyloarthritis

With this approval, RINVOQ® is the first and only Janus Kinase inhibitor approved to treat patients across the spectrum of axial spondyloarthritis (nr-axSpA and ankylosing spondylitis) in the EU.

From AbbVie 29 Jul 2022

UK study finds an increase in cardiovascular diseases and diabetes up to 12 months after COVID-19

Researchers determined whether the incidence of new diabetes mellitus (DM) and cardiovascular diseases (CVDs) increases in a year among those recovering from COVID-19.

21 Jul 2022

Patients who contract COVID-19 face a higher risk of developing cardiovascular diseases and diabetes

Patients who contract COVID-19 face a higher risk of developing cardiovascular diseases and diabetes, particularly in the three months following infection, according to a new study by Emma Rezel-Potts, Martin Gulliford, and colleagues of King's College London, United Kingdom, publishing July 19th in the open access journal PLOS Medicine.

20 Jul 2022

AI vs. clinical reports for the detection of incidental pulmonary embolus on chest CT

According to ARRS' American Journal of Roentgenology (AJR), an AI tool for detection of incidental pulmonary embolus (iPE) on conventional contrast-enhanced chest CT examinations had high NPV and moderate PPV for detection, even finding some iPEs missed by radiologists.

13 Jul 2022

Risk factors associated with shoulder surgery are low, but some need further surgery within a year

Rates of serious complications associated with shoulder surgery are low, but one in 26 patients need further surgery within a year, finds a study in The BMJ today.

7 Jul 2022

Study characterizes long-COVID symptoms in hospitalized and non-hospitalized COVID-19 patients

Scientists have provided a detailed overview on the long-term symptoms experienced by COVID-19 patients after initial primary infection with SARS-CoV-2.

30 Jun 2022

One in 500 men may carry an extra X or Y chromosome which could increase risk of several diseases

Around one in 500 men could be carrying an extra X or Y chromosome – most of them unaware – putting them at increased risk of diseases such as type 2 diabetes, atherosclerosis and thrombosis, say researchers at the universities of Cambridge and Exeter.

10 Jun 2022

The incidence of post-COVID conditions among patients who had received a previous COVID-19 diagnosis

Researchers evaluated the incidence of post-COVID-19 conditions among adults in the United States.

26 May 2022

Low-dose apixaban treatment reduces recurrence of venous thromboembolism compared to anticoagulant discontinuation after negative D-dimer

Patients who have suffered from a first episode of unprovoked venous thromboembolism (VTE) have an eight times higher risk of recurrence if they stop treatment after repeated negative D-dimer tests, instead of continuing with low-dose anticoagulant (apixaban).

20 May 2022

Pulmonary Embolism News and Research

Further Reading

What is the association between COVID-19 and thrombotic events?

Study details post-COVID-19 symptoms and conditions among children and adolescents in the US

French study on cardiovascular disease incidence during COVID pandemic and vaccination campaign

Researchers delve deeper into the structure of protein receptor crucial for cardiovascular health

Higher suPAR levels linked with increased risk of blood clot formation

RINVOQ® (upadacitinib) Approved by European Commission as an Oral Treatment for Adults with Active Non-Radiographic Axial Spondyloarthritis

UK study finds an increase in cardiovascular diseases and diabetes up to 12 months after COVID-19

Patients who contract COVID-19 face a higher risk of developing cardiovascular diseases and diabetes

AI vs. clinical reports for the detection of incidental pulmonary embolus on chest CT

Risk factors associated with shoulder surgery are low, but some need further surgery within a year

Study characterizes long-COVID symptoms in hospitalized and non-hospitalized COVID-19 patients

One in 500 men may carry an extra X or Y chromosome which could increase risk of several diseases

The incidence of post-COVID conditions among patients who had received a previous COVID-19 diagnosis

Low-dose apixaban treatment reduces recurrence of venous thromboembolism compared to anticoagulant discontinuation after negative D-dimer

Incidence of arterial and venous thromboembolism and death in COVID-19 patients

Patients with COVID-19 pneumonitis and moderate to severe ARDS treated with sildenafil

Study investigates COVID-19 vaccination in pregnancy

Role of complement factor H-related protein 5 in venous thromboembolism and COVID-19

Incidence of venous thromboembolism following COVID-19 vaccination

Cancer patients with non-O blood types face higher risk of developing blood clots

Sensing a Healthier Future

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Latest News